Evidence map›Paper›PMID 32572370›Full record

ReviewJournal of bone metabolism2020

Rodent Model of Muscular Atrophy for Sarcopenia Study.

Kyung-Wan Baek, Youn-Kwan Jung, Ji-Seok Kim, Jin Sung Park, Young-Sool Hah, So-Jeong Kim, Jun-Il Yoo

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of bone metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Journal of microbiology and biotechnology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Frontiers in aging neuroscience · 2024
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Natural Compounds Attenuate Denervation-Induced Skeletal Muscle Atrophy.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kyung-Wan BaekDepartment of Physical Education, Gyeongsang National University, Jinju, Korea.ORCID https://orcid.org/0000-0002-8445-3773
Youn-Kwan JungBiomedical Research Institute, Gyoengsang National University Hospital, Gyeongsang National University, Jinju, Korea.ORCID https://orcid.org/0000-0002-5784-6221
Ji-Seok KimDepartment of Physical Education, Gyeongsang National University, Jinju, Korea.
Jin Sung ParkDepartment of Orthopaedic Surgery, Gyoengsang National University Hospital, Gyeongsang National University, Jinju, Korea.ORCID https://orcid.org/0000-0002-6284-9566
Young-Sool HahBiomedical Research Institute, Gyoengsang National University Hospital, Gyeongsang National University, Jinju, Korea.ORCID https://orcid.org/0000-0002-8571-2722
So-Jeong KimDepartment of Convergence of Medical Sciences, Gyeongsang National University, Jinju, Korea.
Jun-Il YooDepartment of Orthopaedic Surgery, Gyoengsang National University Hospital, Gyeongsang National University, Jinju, Korea.ORCID https://orcid.org/0000-0002-3575-4123
Gyeongsang National University Hospital · KRGyeongsang National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hallmark symptom of sarcopenia is the loss of muscle mass and strength without the loss of overall body weight. Sarcopenia patients are likely to have worse clinical outcomes and higher mortality than do healthy individuals. The sarcopenia population shows an annual increase of ~0.8% in the population after age 50, and the prevalence rate is rapidly increasing with the recent worldwide aging trend. Based on International Classification of Diseases, Tenth Revision, a global classification of disease published by the World Health Organization, issued the disease code (M62.84) given to sarcopenia in 2016. Therefore, it is expected that the study of sarcopenia will be further activated based on the classification of disease codes in the aging society. Several epidemiological studies and meta-analyses have looked at the correlation between the prevalence of sarcopenia and several environmental factors. In addition, studies using cell lines and rodents have been done to understand the biological mechanism of sarcopenia. Laboratory rodent models are widely applicable in sarcopenia studies because of the advantages of time savings, cost saving, and various analytical applications that could not be used for human subjects. The rodent models that can be applied to the sarcopenia research are diverse, but a simple and fast method that can cause atrophy or aging is preferred. Therefore, we will introduce various methods of inducing muscular atrophy in rodent models to be applied to the study of sarcopenia.

Indexed as

AgingMuscle, skeletalMuscular atrophyRodentiaSarcopenia

Identifiers

PMID32572370
PMCPMC7297619
OpenAlexW3034144541

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.